Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Colorectal Neoplasms × 5-aminolevulinic acid hexyl ester × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1 Colorectal Neoplasms 1

Interventions

Oxaliplatin 18 Fluorouracil 18 Leucovorin 17 Bevacizumab 15 Irinotecan 12 Cetuximab 12 Capecitabine 8 Radiotherapy 5 Nivolumab 5 regorafenib 4 aflibercept 4 Radiosurgery 4 Neoadjuvant Therapy 4 Drug Therapy 4 Chemotherapy, Adjuvant 4 pembrolizumab 3 atezolizumab 3 Magnetic Resonance Spectroscopy 3 Cyclophosphamide 3 Biopsy 3 trifluridine tipiracil drug combination 2 tremelimumab 2 tislelizumab 2 futuximab 2 fludarabine 2 durvalumab 2 avelumab 2 aldesleukin 2 Trastuzumab 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03272659 2019-09-18

PDD

Sir Mortimer B. Davis - Jewish General Hospital

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡